Fujifilm’s Chinese pharma patent licensing deal marks a milestone in its IP-driven transformation

Fujifilm announced this week that it had entered into a patent licensing agreement with Chinese company Zhejiang Hisun Pharmaceutical – a transaction that represents the latest step in its realignment as a life sciences-focused business.

The deal…

Get unlimited access to all IAM content